Cancer Biopsy Market Size, Share Report, Analysis, Trends, Growth, Forecast, 2024 - 2032

Cancer Biopsy Market

Cancer Biopsy Market - By Product (Kits & Consumables and Instruments), By Type (Tissue Biopsies and Liquid Biopsies), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Healthcare Report Format : PDF Pages: 150 Report Code: ZMR-6534 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 5.22 Billion USD 79.78 Billion 35.4% 2023

Cancer Biopsy Market

Request Free Sample

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Cancer Biopsy Market, 2018–2028(USD Billion)
    • 2.2. Cancer Biopsy Market: Snapshot
  • Chapter 3. Global Cancer Biopsy Market– Type Analysis
    • 3.1. Cancer Biopsy Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Massive application of liquid biopsy and breakthroughs in biopsy methods are set to spur growth of cancer biopsy market in upcoming years.
      • 3.2.2. Launching of new methods like next-generation sequencing will embellish industry size within next few years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Product
      • 3.4.2. Market attractiveness analysis By Type
  • Chapter 4. Global Cancer Biopsy Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Cancer Biopsy Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Cancer Biopsy Market– Product Analysis
    • 5.1. Global Cancer Biopsy Market overview: By Product
      • 5.1.1. Global Cancer Biopsy Market share, By Product, 2020 and 2028
    • 5.2. Kits & Consumables
      • 5.2.1. Global Cancer Biopsy Market by Kits & Consumables, 2018–2028(USD Billion)
    • 5.3. Instruments
      • 5.3.1. Global Cancer Biopsy Market by Instruments, 2018–2028(USD Billion)
  • Chapter 6. Global Cancer Biopsy Market– Type Analysis
    • 6.1. Global Cancer Biopsy Market overview: By Type
      • 6.1.1. Global Cancer Biopsy Market share, By Type, 2020 and 2028
    • 6.2. Tissue Biopsies
      • 6.2.1. Global Cancer Biopsy Market by Tissue Biopsies , 2018–2028(USD Billion)
    • 6.3. Liquid Biopsies
      • 6.3.1. Global Cancer Biopsy Market by Liquid Biopsies, 2018–2028(USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Qiagen N.V.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Hulogic, Inc.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Illumina, Inc.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Development
    • 7.4. Biocept, Inc.
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Development
    • 7.5. ANGLE Plc
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Danaher Corporation
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Roche Hulding AG
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. GRAIL, Inc.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Freenome Huldings, Inc.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Lucence Diagnostics Private Limited
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Epigenomics AG
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Product Portfolio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development
    • 7.12. HelioHealth
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Product Portfolio
      • 7.12.4. Business Strategy
      • 7.12.5. Recent Development
    • 7.13. Genesystems, Inc.
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Product Portfolio
      • 7.13.4. Business Strategy
      • 7.13.5. Recent Development
    • 7.14. Natera, Inc.
      • 7.14.1. Overview
      • 7.14.2. Financials
      • 7.14.3. Product Portfolio
      • 7.14.4. Business Strategy
      • 7.14.5. Recent Development
    • 7.15. Chronix Biomedical, Inc.
      • 7.15.1. Overview
      • 7.15.2. Financials
      • 7.15.3. Product Portfolio
      • 7.15.4. Business Strategy
      • 7.15.5. Recent Development
    • 7.16. Personal Genome Diagnostics Inc.
      • 7.16.1. Overview
      • 7.16.2. Financials
      • 7.16.3. Product Portfolio
      • 7.16.4. Business Strategy
      • 7.16.5. Recent Development
    • 7.17. Personalis, Inc.
      • 7.17.1. Overview
      • 7.17.2. Financials
      • 7.17.3. Product Portfolio
      • 7.17.4. Business Strategy
      • 7.17.5. Recent Development
    • 7.18. Biodesix
      • 7.18.1. Overview
      • 7.18.2. Financials
      • 7.18.3. Product Portfolio
      • 7.18.4. Business Strategy
      • 7.18.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Cancer Biopsy Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Cancer Biopsy Marketattractiveness, By Product
6. Global Cancer Biopsy Marketattractiveness, By Type
7. Global Cancer Biopsy Marketshare by Product ,2020 and 2028 (USD Billion)
8. Global Cancer Biopsy Marketby Kits & Consumables, 2018–2028(USD Billion)
9. Global Cancer Biopsy Marketby Instruments, 2018–2028(USD Billion)
10. Global Cancer Biopsy Marketshare by Type ,2020 and 2028 (USD Billion)
11. Global Cancer Biopsy Marketby Tissue Biopsies , 2018–2028(USD Billion)
12. Global Cancer Biopsy Marketby Liquid Biopsies, 2018–2028(USD Billion)
13. Global Cancer Biopsy Marketshare, by Region, 2020 and 2028
14. North America Cancer Biopsy Market, 2018–2028(USD Billion)
15. Europe Cancer Biopsy Market, 2018–2028(USD Billion)
16. Asia Pacific Cancer Biopsy Market, 2018–2028(USD Billion)
17. Latin America Cancer Biopsy Market, 2018–2028(USD Billion)
18. The Middle East and Africa Cancer Biopsy Market, 2018–2028(USD Billion)
 


Table Of Tables

List of Tables

1. Global Cancer Biopsy Market: snapshot
2. Drivers of the Cancer Biopsy Market: impact analysis
3. North America Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
4. North America Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
5. The U.S. Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
6. The U.S. Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
7. Rest of North America Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
8. Rest of North America Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
9. Europe Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
10. Europe Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
11. UK Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
12. UK Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
13. France Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
14. France Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
15. Germany Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
16. Germany Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
17. Rest of Europe Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
18. Rest of Europe Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
19. Asia Pacific Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
20. Asia Pacific Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
21. China Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
22. China Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
23. Japan Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
24. Japan Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
25. India Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
26. India Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
27. Rest of Asia Pacific Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
28. Rest of Asia Pacific Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
29. Latin America Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
30. Latin America Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
31. Brazil Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
32. Brazil Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
33. Rest of Latin America Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
34. Rest of Latin  America Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
35. The Middle East and Africa Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
36. The Middle East and Africa Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
37. Saudi Arabia Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
38. Saudi Arabia Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
39. South Africa Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
40. South Africa Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)

 
 

Methodology

FrequentlyAsked Questions

A cancer biopsy is a medical procedure to remove tissue for testing. It helps diagnose cancer and determine its type
The global Cancer Biopsy market is expected to be driven by the rising cancer incidence and demand for early, accurate diagnosis. Advancements in imaging-guided and minimally invasive biopsy techniques support adoption.
According to study, the global Cancer Biopsy market size was worth around USD 5.22 Billion in 2023 and is predicted to grow to around USD 79.78 Billion By 2032.
The global Cancer Biopsy market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 35.4% during the forecast period from 2024-2032.
The global Cancer Biopsy industry is projected to be challenged by Challenges include procedural risks, high diagnostic costs, and need for skilled clinicians.
The Opportunities include rising cancer incidence, minimally invasive techniques, precision oncology, and early detection demand will offer significant growth opportunities in the Cancer Biopsy market.
Liquid biopsy and minimally invasive techniques; AI-assisted pathology interpretation; image-guided and precision sampling innovations are the emerging trends and innovations impacting the Cancer Biopsy market.
The global Cancer Biopsy market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Cancer Biopsy market are; Qiagen N.V., Hologic, Inc., Illumina, Inc., Biocept, Inc., ANGLE Plc, Danaher Corporation, Roche Holding AG, GRAIL, Inc., Freenome Holdings, Inc., Lucence Diagnostics Private Limited, Epigenomics AG, HelioHealth, Genesystems, Inc., Natera, Inc., Chronix Biomedical , Inc., Personal Genome Diagnostics Inc., Personalis Inc., and Biodesix. and others.
The report explores crucial aspects of the Cancer Biopsy market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

Market InsightsGlobal Market Size AnalysisOverviewGrowth DriversReport ScopeRegional LandscapeCompetitive LandscapeThe global Market is segmented as follows:By ProductBy TypeBy Region

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed